Table 2.
The total numbers of upregulated and downregulated genes in EC, CA3, both in EC and CA3 and CB, at 1 d (D), 1 week (W), 3–4 months after SE (M), and in the non-SE group (nS), obtained using three different p values (0.05, 0.01, and 0.001)
| D | W | M | nS | |
|---|---|---|---|---|
| EC | ||||
| p < 0.05 | 1241 up (13%) | 1107 up (15%) | 369 up (45%) | 285 up (68%) |
| 1307 down (13%) | 1133 down (15%) | 313 down (53%) | 326 down (64%) | |
| p < 0.01 | 761 up (4%) | 786 up (4%) | 114 up (29%) | 63 up (52%) |
| 740 down (4%) | 564 down (6%) | 95 down (35%) | 85 down (39%) | |
| p < 0.001 | 330 up (1%) | 449 up (1%) | 24 up (14%) | 6 up (55%) |
| 289 down (1%) | 194 down (2%) | 18 down (18%) | 13 down (25%) | |
| CA3 | ||||
| p < 0.05 | 1050 up (15%) | 775 up (20%) | 609 up (26%) | 230 up (58%) |
| 1128 down (15%) | 625 down (25%) | 627 down (25%) | 246 down (64%) | |
| p < 0.01 | 610 up (5%) | 464 up (7%) | 262 up (12%) | 53 up (59%) |
| 615 down (5%) | 221 down (14%) | 243 down (13%) | 46 down (68%) | |
| p < 0.001 | 285 up (1%) | 244 up (1%) | 77 up (4%) | 6 up (52%) |
| 192 down (2%) | 40 down (8%) | 54 down (6%) | 7 down (45%) | |
| EC and CA3 | ||||
| p < 0.05 | 726 up (1%) | 559 up (2%) | 87 up (10%) | 16 up (54%) |
| 763 down (1%) | 325 down (3%) | 53 down (16%) | 10 down (87%) | |
| p < 0.01 | 391 up (0%) | 356 up (0%) | 25 up (1%) | 0 up |
| 356 down (0%) | 100 down (0%) | 12 down (3%) | 0 down | |
| p < 0.001 | 162 up (0%) | 186 up (0%) | 15 up (1%) | 0 up |
| 82 down (0%) | 13 down (0%) | 4 down (2%) | 0 down | |
| CB | ||||
| p < 0.05 | 254 up (61%) | 334 up (46%) | ||
| 232 down (67%) | 359 down (43%) | |||
| p < 0.01 | 53 up (55%) | 99 up (31%) | ||
| 50 down (62%) | 83 down (37%) | |||
| p < 0.001 | 8 up (39%) | 16 up (19%) | ||
| 5 down (62%) | 10 down (31%) |
The FDR is indicated in parentheses.